Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)

NCT07050472 · clinicaltrials.gov ↗
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Anhui Shi, MD